High-risk patient characteristics. Results of the OSCAR Study: epidemiological part

• Main Authors: S. A. Shalnova, A. D. Deev
• Format: Article
• Language: Russian
• Published: «SILICEA-POLIGRAF» LLC 2006-10-01
• Series: Кардиоваскулярная терапия и профилактика
• Subjects: epidemiological study; high risk; coronary heart disease; statins; educational program oscar
• Online Access: https://cardiovascular.elpub.ru/jour/article/view/1302
• ISSN: 1728-8800; 2619-0125

Aim. Program OSCAR-2006 has been initiated with an aim to identify high-risk patients in real-world clinical practice settings. The article presents the results from the epidemiological part of the Program. Material and methods. OSCAR-2006 Study included 235 doctors from 36 Russian cities, and 7098 patients: 3673 males (51,8%), 3425 females (48,2%), aged 25-75 years, with myocardial infarction (MI) and/or myocardial revascularization, and/or stable angina, diabetes mellitus (DM), peripheral artery disease in anamnesis, and, therefore, high cardiovascular risk. Socio-demographic, anthropometric, clinical and some laboratory parameters were assessed. Results. More than 50% of males and 8,8% of females were current smokers. High blood pressure was diagnosed in 83,4%, dyslipidemia – in >70%, DM – in 20% of the patients examined. Therefore, 97,4% of the participants had at least one risk factor. Coronary heart disease (CHD) was diagnosed in almost 80%, mostly in males. Males had MI in anamnesis twice as often as females. By the study start, 6% of the patients had suffered stroke, and 20% had peripheral artery disease. As regards the treatment, 87,2% of the participants received antihypertensive therapy: about 60% - at least 3 antihypertensive medications, 10% - two medications, and only 8,7% were on monotherapy. Conclusion. Studies devoted to clinical practice analysis, problems of high-risk patient identification, adequate prevention and treatment in such individuals should be regarded as an important step towards population-level reduction of cardiovascular risk.